RS55392B1 - Brzo topljiva formulacija za oralno doziranje - Google Patents
Brzo topljiva formulacija za oralno doziranjeInfo
- Publication number
- RS55392B1 RS55392B1 RS28404A RSP28404A RS55392B1 RS 55392 B1 RS55392 B1 RS 55392B1 RS 28404 A RS28404 A RS 28404A RS P28404 A RSP28404 A RS P28404A RS 55392 B1 RS55392 B1 RS 55392B1
- Authority
- RS
- Serbia
- Prior art keywords
- granules
- oral dosage
- prepared
- dosage forms
- dosage formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Obezbeđene su granule za proizvodnju unapređenih brzotopljivih farmaceutskih oralno doznih oblika. Osim jednog leka, granule se sastavljaju od kombinacije podloge, koja se sastoji od superdezintegratora (od dva agensa izabranih iz grupe krospovidona i kroskarmeloze natrijuma) dispergujućeg sredstva i sredstva za vezivanje i mogu, takođe, uključuti druge konvencionalne sastojke, kao što su sredstva za zaslađivanje i ukus. Granule, o kojima je reč, imaju prednost u tome što su stabilne i što se mogu pripremiti bez pomoći rastvarača i bez potrebe za posebnim uslovima sredine ili obrade. Dozni oblici, posebno tablete, koji se pripremaju od njih na konvencionalnoj opremi, raspadaju se u ustima za otprilike dvadeset pet sekundi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/031530 WO2003030868A1 (en) | 2001-10-09 | 2001-10-09 | Flashmelt oral dosage formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
RS55392B1 true RS55392B1 (sr) | 2017-03-31 |
Family
ID=32505152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS28404A RS55392B1 (sr) | 2001-10-09 | 2001-10-09 | Brzo topljiva formulacija za oralno doziranje |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1441698B1 (sr) |
JP (1) | JP2005507397A (sr) |
KR (1) | KR20040045499A (sr) |
CN (1) | CN100490810C (sr) |
BR (1) | BR0117147A (sr) |
CA (1) | CA2462886C (sr) |
HR (1) | HRP20040322A2 (sr) |
HU (1) | HUP0500638A3 (sr) |
IL (1) | IL161143A0 (sr) |
IS (1) | IS7208A (sr) |
MX (1) | MXPA04003346A (sr) |
NO (1) | NO340570B1 (sr) |
RS (1) | RS55392B1 (sr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1901749T3 (en) * | 2005-05-18 | 2016-10-24 | Raptor Pharmaceuticals Inc | Aerosolized fluoroquinolones AND USES THEREOF |
KR100780553B1 (ko) * | 2005-08-18 | 2007-11-29 | 한올제약주식회사 | 메트포르민 서방정 및 그의 제조방법 |
CN101322709B (zh) * | 2007-06-12 | 2011-03-02 | 成都康弘药业集团股份有限公司 | 一种含有阿立哌唑的药物组合物及其制备方法 |
WO2010106936A1 (ja) * | 2009-03-16 | 2010-09-23 | ニプロ株式会社 | 口腔内崩壊錠 |
WO2011049122A1 (ja) * | 2009-10-21 | 2011-04-28 | 第一三共株式会社 | プラバスタチンナトリウム口腔内速崩壊錠及びその製造方法 |
HU1000278D0 (en) * | 2010-05-28 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | Novel pharmaceutical use uf silicic acid |
CN102397552B (zh) * | 2010-09-10 | 2016-06-08 | 广州自远生物科技有限公司 | 一种含喹诺酮类的药物复合制剂及其制备方法和应用 |
JP2012121850A (ja) * | 2010-12-09 | 2012-06-28 | Otsuka Pharmaceut Co Ltd | アリピプラゾールの経口速溶性組成物 |
CN102357086A (zh) * | 2011-11-01 | 2012-02-22 | 上海理工大学 | 一种头孢丙烯口腔崩解片 |
KR101285008B1 (ko) * | 2012-04-18 | 2013-07-10 | 제일약품주식회사 | 저용량 엔테카비어의 경구투여 제제의 제조방법 |
CN102670533B (zh) * | 2012-05-17 | 2017-06-16 | 浙江华海药业股份有限公司 | 稳定的阿立哌唑口腔崩解片及其制备方法 |
CN104138382B (zh) * | 2014-08-14 | 2015-08-12 | 广州一品红制药有限公司 | 一种含盐酸左氧氟沙星的组合物 |
JP6558530B2 (ja) * | 2015-04-20 | 2019-08-14 | 高田製薬株式会社 | アリピプラゾール医薬品製剤 |
JP2015172084A (ja) * | 2015-07-06 | 2015-10-01 | 大塚製薬株式会社 | アリピプラゾールの経口速溶性組成物 |
CN106913548A (zh) * | 2015-12-28 | 2017-07-04 | 药源药物化学(上海)有限公司 | 一种阿立哌唑口崩片及其制备方法 |
JP6572257B2 (ja) * | 2017-05-16 | 2019-09-04 | 大塚製薬株式会社 | アリピプラゾールの経口速溶性組成物 |
KR101808513B1 (ko) | 2017-06-22 | 2018-01-18 | 임철수 | 한대의본체로 다수가 사용하는 컴퓨터장치 및 그 운영방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994348A (en) * | 1995-06-07 | 1999-11-30 | Sanofi | Pharmaceutical compositions containing irbesartan |
AU3726597A (en) * | 1996-07-23 | 1998-02-10 | Fmc Corporation | Disintegrant composition for dispersible solids |
CA2311734C (en) * | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
-
2001
- 2001-10-09 RS RS28404A patent/RS55392B1/sr unknown
- 2001-10-09 IL IL16114301A patent/IL161143A0/xx unknown
- 2001-10-09 EP EP01979614.3A patent/EP1441698B1/en not_active Expired - Lifetime
- 2001-10-09 JP JP2003533901A patent/JP2005507397A/ja active Pending
- 2001-10-09 CA CA2462886A patent/CA2462886C/en not_active Expired - Lifetime
- 2001-10-09 MX MXPA04003346A patent/MXPA04003346A/es unknown
- 2001-10-09 KR KR10-2004-7005155A patent/KR20040045499A/ko not_active Application Discontinuation
- 2001-10-09 HU HU0500638A patent/HUP0500638A3/hu unknown
- 2001-10-09 CN CNB01823853XA patent/CN100490810C/zh not_active Expired - Lifetime
- 2001-10-09 BR BRPI0117147-0A patent/BR0117147A/pt active Search and Examination
-
2004
- 2004-04-02 NO NO20041383A patent/NO340570B1/no not_active IP Right Cessation
- 2004-04-05 HR HRP20040322 patent/HRP20040322A2/hr not_active Application Discontinuation
- 2004-04-06 IS IS7208A patent/IS7208A/is unknown
Also Published As
Publication number | Publication date |
---|---|
CA2462886C (en) | 2013-07-30 |
CN1561200A (zh) | 2005-01-05 |
JP2005507397A (ja) | 2005-03-17 |
HRP20040322A2 (en) | 2004-12-31 |
NO20041383L (no) | 2004-06-01 |
CN100490810C (zh) | 2009-05-27 |
EP1441698B1 (en) | 2018-05-02 |
EP1441698A4 (en) | 2008-08-13 |
NO340570B1 (no) | 2017-05-15 |
HUP0500638A3 (en) | 2008-04-28 |
IL161143A0 (en) | 2004-08-31 |
IS7208A (is) | 2004-04-06 |
HUP0500638A2 (en) | 2007-02-28 |
MXPA04003346A (es) | 2004-09-28 |
BR0117147A (pt) | 2006-05-09 |
EP1441698A1 (en) | 2004-08-04 |
CA2462886A1 (en) | 2003-04-17 |
KR20040045499A (ko) | 2004-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS55392B1 (sr) | Brzo topljiva formulacija za oralno doziranje | |
TR200001810A2 (tr) | Hemen Eriyen Oral Dozaj Formülasyonu. | |
RS50937B (sr) | Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii | |
IL139227A0 (en) | N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders | |
NO20023313D0 (no) | Nye substituerte benzimidazol doseringsformer og fremgangsmåte for anvendelse av samme | |
CA2481848A1 (en) | Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation | |
IL163831A (en) | Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof | |
EA017764B8 (ru) | Фармацевтическая композиция, способ ее получения и способ лечения вирусных заболеваний с ее использованием | |
UA84266C2 (uk) | Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування | |
HUP0303891A3 (en) | Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
BRPI0417043A (pt) | composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição | |
ME00864B (me) | Farmaceutski sastav koji sadrži inhibitore protonske pumpe | |
DK1341524T3 (da) | Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel | |
MY127350A (en) | Flash-melt oral dose formulations | |
ID28510A (id) | Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 | |
NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
DK1558219T3 (da) | Farmaceutisk formulering af olanzapin | |
HRP20000781B1 (en) | Effervescent preparations | |
WO1999047172A3 (en) | Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes | |
ITMI20020872A1 (it) | Derivati dell'iperforina loro uso e formulazioni che li contengono | |
EP1513512A4 (en) | SOLUBLE STABLE PHARMACEUTICAL COMPOSITION FOR THE ADMINISTRATION OF HIV PROTEASE INHIBITORS AND METHOD FOR THE PREPARATION OF CONCENTRATED PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF HIV PROTEASE INHIBITORS. | |
DK1587810T3 (da) | Nye substituerede [1,4]benzodioxino[2,3-e]isoindolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK1129714T3 (da) | Anvendelse af tiludronsyre og dens derivater hos fjerkræ til fremstilling af et lægemiddel, der er beregnet til at forebygge og behandle osteoporose | |
TH77592B (th) | "รูปยาตามขนาดยาที่มีสารยับยั้ง pde4 เป็นสารออกฤทธิ์" |